Events
Speaker
Philip Kantoff, MD, FASCO – chairman and chief executive officer of Convergent Therapeutics
Topic
Targeted radiopharmaceutical therapy
Groups
Advanced, Newly Diagnosed, Active Surveillance
Sorry, you must be logged in to see posts.
